DE602004020463D1 - Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten - Google Patents

Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten

Info

Publication number
DE602004020463D1
DE602004020463D1 DE602004020463T DE602004020463T DE602004020463D1 DE 602004020463 D1 DE602004020463 D1 DE 602004020463D1 DE 602004020463 T DE602004020463 T DE 602004020463T DE 602004020463 T DE602004020463 T DE 602004020463T DE 602004020463 D1 DE602004020463 D1 DE 602004020463D1
Authority
DE
Germany
Prior art keywords
preparation
tectoridine
effective ingredients
medicaments containing
isoflavone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004020463T
Other languages
English (en)
Inventor
Xuemin Xu
Chongjun Yuan
Jia Wang
Shangbin Qi
Hai Yin
Yanming Zeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU DIKANG PHARMACEUTICAL
SICHUAN DIKANG SCI TECH PHARMA
Original Assignee
CHENGDU DIKANG PHARMACEUTICAL
SICHUAN DIKANG SCI TECH PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU DIKANG PHARMACEUTICAL, SICHUAN DIKANG SCI TECH PHARMA filed Critical CHENGDU DIKANG PHARMACEUTICAL
Publication of DE602004020463D1 publication Critical patent/DE602004020463D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DE602004020463T 2003-05-15 2004-05-14 Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten Expired - Lifetime DE602004020463D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN03117865 2003-05-15
PCT/CN2004/000481 WO2004111027A1 (fr) 2003-05-15 2004-05-14 Derives isoflavoniques de tectoridine, preparation de ces derives et medicaments antiviraux contenant ces derives comme ingredients efficaces

Publications (1)

Publication Number Publication Date
DE602004020463D1 true DE602004020463D1 (de) 2009-05-20

Family

ID=33546175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020463T Expired - Lifetime DE602004020463D1 (de) 2003-05-15 2004-05-14 Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten

Country Status (9)

Country Link
US (1) US7902253B2 (de)
EP (1) EP1630160B1 (de)
JP (1) JP4654187B2 (de)
KR (1) KR101099967B1 (de)
CN (1) CN1285586C (de)
AT (1) ATE427944T1 (de)
DE (1) DE602004020463D1 (de)
RU (1) RU2332410C2 (de)
WO (1) WO2004111027A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448450C (zh) * 2005-04-01 2009-01-07 四川省中药研究所 鸢尾总黄酮提取物的用途
CN100431581C (zh) * 2006-01-20 2008-11-12 丽珠医药集团股份有限公司 治疗禽流感的中药组合物、制备方法及其用途
CN1907979B (zh) * 2006-08-18 2010-05-12 山东省医学科学院药物研究所 8-亚甲基-甲胺-尼泊尔鸢尾异黄酮和以该化合物为活性成分的药物组合物
CN101723926B (zh) * 2008-10-10 2012-02-22 四川省中医药科学院 一种异黄酮衍生物及其制备方法和用途
MX2012007305A (es) * 2009-12-22 2012-07-04 Procter & Gamble Composicion liquida de limpieza y/o lavado.
EP2560652A4 (de) 2010-04-23 2013-08-14 Kineta Inc Antivirale verbindungen
CN101863870B (zh) * 2010-06-03 2012-07-25 中国药科大学 一种鸢尾苷元衍生物、其制法及其治疗前列腺疾病的应用
EP2678019A4 (de) 2011-02-25 2015-05-13 Kineta Inc Verfahren und zellen zur identifizierung von rig-i-pfadregulatoren
CN102603834B (zh) * 2012-01-17 2014-03-12 武汉回盛生物科技有限公司 一种从川射干中提取、分离射干苷的方法
CN102525907B (zh) * 2012-02-22 2013-06-05 四川省中医药科学院 鸢尾苷元磺酸钠注射液
CN103202807B (zh) * 2013-04-25 2014-10-01 四川省中医药科学院 射干苷元注射液
CN104606148B (zh) * 2014-12-29 2017-10-27 重庆药友制药有限责任公司 一种注射用炎琥宁制剂及其制备方法
CN106554339B (zh) * 2016-11-01 2019-03-08 四川省中医药科学院 一种异黄酮衍生物及其制备方法和用途
CN109666015B (zh) * 2018-12-13 2021-04-16 四川省中医药科学院 一种射干苷元Mannich碱衍生物及其制备方法和应用
WO2020185620A1 (en) * 2019-03-08 2020-09-17 Microbiotix, Inc. Inhibition of adenovirus with filociclovir
CN110396077B (zh) * 2019-04-19 2021-02-12 四川省中医药科学院 一种射干苷元磺酸钠的制备方法
CN115819391A (zh) * 2021-09-17 2023-03-21 中国科学院上海药物研究所 一类黄芩素衍生物、其制备方法和用途
CN115093388B (zh) * 2022-07-27 2023-12-05 湖南正清制药集团股份有限公司 一种黄酮类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4352782A (en) * 1981-02-20 1982-10-05 Rocket Research Company Catalytic gas generator
US4342753A (en) * 1981-06-15 1982-08-03 American Cyanamid Company Carboxyalkyl derivatives of rutin poly(H-)sulfate
JPS6112A (ja) * 1984-06-08 1986-01-06 Takeda Chem Ind Ltd 混合粉砕物
DE3485000D1 (de) * 1983-06-28 1991-10-10 Takeda Chemical Industries Ltd Gemahlene mischung.
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne

Also Published As

Publication number Publication date
US20070123566A1 (en) 2007-05-31
CN1594308A (zh) 2005-03-16
KR20060034221A (ko) 2006-04-21
ATE427944T1 (de) 2009-04-15
EP1630160A4 (de) 2008-01-16
CN1285586C (zh) 2006-11-22
JP2007515389A (ja) 2007-06-14
RU2332410C2 (ru) 2008-08-27
JP4654187B2 (ja) 2011-03-16
WO2004111027A1 (fr) 2004-12-23
EP1630160A1 (de) 2006-03-01
EP1630160B1 (de) 2009-04-08
US7902253B2 (en) 2011-03-08
KR101099967B1 (ko) 2011-12-28
RU2005138163A (ru) 2007-06-27

Similar Documents

Publication Publication Date Title
DE602004020463D1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
DE60110415D1 (de) Neue Pyrazin-Derivate oder Salze davon, pharmazeutische Zusammensetzungen, die die Derivate oder deren Salze enthalten und Intermediäre zur Herstellung der Derivate
EA200400432A1 (ru) Производные мочевины
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
ATE99302T1 (de) Substituierte flavonoide verbindungen, ihre salze, ihre herstellung und die enthaltende arnzeizusammensetzungen.
DE69712042T2 (de) Thiazolylbenzofuranderivate und pharmazeutische zusammensetzungen die sie enthalten
ATE159250T1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
BR0208053A (pt) Sìntese de moléculas isoflavonas diméricas, composições contendo as mesmas e seus usos como agentes terapêuticos
DE60024857D1 (de) Neue verbindungen
DE69210091T2 (de) Leukotrien-B4-Antagonisten
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3750464D1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
BRPI0412928A (pt) dibenzo[b,f]oxepina-10-carboxamidas e usos farmacêuticos das mesmas
IT1266571B1 (it) Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari
ATE179424T1 (de) N-heteroaryl substituierte propanamid-derivate brauchbar zur behandlung cardiovascularer krankheiten
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ATE325109T1 (de) Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten
DE69400352T2 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
DE69720496T2 (de) Benzimidazolderivate
DE69729565D1 (de) Neue pyridoncarbonsäure-derivate oder salze dieser derivate und antibakterielle mittel, die diese als aktiven wirkstoff enthalten
DE3787451D1 (de) Antibakterielles Mittel für Anwendung bei Säugetieren mit Cephalosporinverbindungen als effektiven Bestandteil.
AR022044A1 (es) Derivados de 1,5-benzodiazepina
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition